Personalisation of warfarin therapy using thermal ink-jet printing
-
Add time:07/21/2019 Source:sciencedirect.com
Warfarin is a widely used anticoagulant that is critical in reducing patient morbidity and mortality associated with thromboembolic disorders. However, its narrow therapeutic index and large inter-individual variability can lead to complex dosage regimes. Formulating warfarin as an orodispersible film (ODF) using thermal ink-jet (TIJ) printing could enable personalisation of therapy to simplify administration. Commercial TIJ printers are currently unsuitable for printing the milligram dosages, typically required for warfarin therapy. As such, this study aimed to modify a commercial TIJ printing system to formulate personalised warfarin ODFs containing therapeutic dosages. A TIJ printer was modified successfully with the printer functionality intact; the substrate (paper) rolling mechanism of the printer was replaced by printing onto a stationary stage. Free film substrates were composed of hydroxypropyl methylcellulose (20%w/w) and glycerol (3%w/w). The resulting ODFs were characterised for morphology, disintegration, solid-state properties and drug content. Printed film stability was assessed at 40 °C/75% relative humidity for 30 days. Therapeutic warfarin doses (1.25 and 2.5 mg) were successfully printed onto the film substrates. Excellent linearity was observed between the theoretical and measured dose by changing the warfarin feed concentration (R2 = 0.9999) and length of the print objective, i.e. the Y-value, (R2 = 0.9998). Rapid disintegration of the ODFs was achieved. As such, this study successfully formulated personalised warfarin ODFs using a modified TIJ printer, widening the range of applications for TIJ printing to formulate narrow therapeutic index drugs.
We also recommend Trading Suppliers and Manufacturers of (R)-7-Hydroxy Warfarin (cas 63740-76-1). Pls Click Website Link as below: cas 63740-76-1 suppliers
Prev:Warfarin Use Is Associated With Progressive Coronary Arterial Calcification
Next:Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS)07/20/2019
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification07/19/2019
- Monitoring unbound warfarin in drug combination therapy by pharmacokinetics and fluorospectrometry07/18/2019
- Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study07/17/2019
- Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery07/16/2019
- Warfarin-exposed zebrafish embryos resembles human warfarin embryopathy in a dose and developmental-time dependent manner – From molecular mechanisms to environmental concerns07/15/2019
- Maintenance dose of warfarin beyond time in therapeutic range for preventing vascular events07/14/2019
- The Effect of Compound Danshen Dripping Pills on the Dose and Concentration of Warfarin in Patients with Various Genetic Polymorphisms07/13/2019
- Additive manufacturing of personalized orodispersible warfarin films07/12/2019
-
Health and Chemical more >
-
Related Products


